جستجوی استاد راهنمای دانشگاهی

• Geotechnical Engineering
• Environmental Engineering
• Waste Management
• +۳ مورد دیگر

Dr. Yuekai Xie is a Research Associate in the School of Engineering and Technology at the University of New South Wales (UNSW) Canberra campus. With a PhD in civil (geotechnical) engineering from UNSW completed in 2022 and a BSc from Monash University (2017), Dr. Xie has established himself as a researcher specializing in geoenvironmental engineering and sustainable materials. Dr. Xie's educational background includes: PhD in Civil (Geotechnical) Engineering, University of New South Wales, 2022 BSc, Monash University, 2017 Dr. Xie's primary research interests focus on the geoenvironmental behaviour of municipal solid wastes , sustainable cement materials , and the geoenvironmental impacts of microplastic contamination on natural soils . His work bridges the gap between waste management and civil engineering, developing innovative solutions for recycling waste materials in construction applications while addressing environmental concerns. He has made significant contributions to understanding how microplastics affect soil properties and how waste materials can be repurposed in sustainable construction. Analysis of Dr. Xie's recent publications (2023-2025) reveals a strong focus on sustainable geopolymer composites, microplastic impacts on soil behavior, and waste material recycling in construction. His research demonstrates a clear trajectory toward developing environmentally friendly construction materials while addressing waste management challenges. The interdisciplinary nature of his work connects geotechnical engineering, environmental science, and materials engineering, with particular emphasis on practical applications for sustainable infrastructure development. Dr. Xie has published extensively in high-impact journals including Waste Management, Construction and Building Materials, and Science of the Total Environment, with numerous publications appearing in 2024-2025. His research demonstrates consistent productivity and growing influence in the fields of geoenvironmental engineering and sustainable construction materials.

• Vascular Signalling
• Neurovascular Endothelial Cell Biology
• Protein Phosphorylation
• +۴ مورد دیگر

Professor Patric Turowski is a Professor of Vascular Signalling at the Institute of Ophthalmology, University College London. He has been with UCL since 2004, initially as a Lecturer in Ocular Cell Biology, then promoted to Senior Lecturer in Vascular Cell Biology in 2011, and currently holds the position of Professor of Vascular Signalling. He also served as a Visiting Professor at Uppsala University, Sweden from 2019 to 2021. His educational background includes a PhD and Diploma from the University of Basel, Switzerland. His postdoctoral training included work at CNRS research institutes in Montpellier, France, and at the UCL Institute of Ophthalmology under John Greenwood. Professor Turowski's research focuses on signalling by reversible phosphorylation in neurovascular endothelial cell biology, with particular emphasis on: VEGF-independent regulation of pathological vascular leakage, regulation of leakage by caveolae, and drug transport across the blood-brain barrier. His work bridges vascular biology, neuroscience, and ophthalmology, with implications for understanding and treating conditions affecting the blood-brain and blood-retinal barriers. His recent publications demonstrate a strong focus on vascular permeability mechanisms, endothelial cell signaling pathways, and the development of diagnostic biomarkers for diabetic retinopathy and therapeutic approaches for neurodegenerative diseases. His research shows increasing interdisciplinary collaboration across multiple institutions and countries. George Heller Award from Controlled Release Society (2019) Professor Turowski serves on editorial boards for Frontiers in Cell and Developmental Biology, Cells, and Vascular Pharmacology. He was President of the UK Cell Adhesion Society in 2018 and participates in grant assessment for the Biotechnology and Biological Sciences Research Council. At UCL, he teaches postgraduate courses on vascular permeability and barriers, experimental modeling techniques, and cell biology methods in eye research, and chairs the departmental Ophthalmology Basic & Applied Science Exam Board.

Dirk Bumannمشاهده پروفایل

استاد

• Infection Biology
• Bacterial Pathogenesis
• Antibiotic Resistance
• +۷ مورد دیگر

Dirk Bumann is a Full Professor of Infection Biology at the Biozentrum, University of Basel, where he leads a research group focused on bacterial pathogenesis and antimicrobial resistance. His laboratory investigates the complex interactions between bacterial pathogens like Salmonella and Pseudomonas aeruginosa and host tissues, with particular emphasis on how nutrient availability in host environments affects bacterial behavior and antibiotic efficacy. As a director of the NCCR AntiResist initiative, he plays a key role in Switzerland's national effort to combat antimicrobial resistance through innovative research approaches. Professor Bumann's research interests center on infection biology , particularly the metabolic adaptation of bacterial pathogens during infection . His team has made seminal discoveries regarding how host-imposed nutrient deprivation (particularly magnesium and iron limitation) creates environments where bacteria become more resilient to antibiotics, challenging previous assumptions about bacterial persisters. Using advanced techniques including single-cell analysis , whole-organ tomography , and mass spectrometry , his group examines bacterial behavior in physiologically relevant conditions that better mimic human infections than traditional laboratory methods. Analysis of his recent publications reveals a consistent focus on host-pathogen metabolic interactions and their implications for antibiotic treatment failure . His 2025 Nature paper fundamentally challenges the persister hypothesis by demonstrating that nutrient starvation—not specialized bacterial subpopulations—is the primary reason for antibiotic treatment failures in Salmonella infections. This work highlights the critical importance of studying bacterial pathogens in conditions that accurately reflect the host environment. Selected Awards & Honors: Elected Member of European Academy of Microbiology (2019) Elected Member of EMBO (2015) Pettenkofer Prize of the City of Munich (2015) "Go-Bio" Award (2007) EMBO Young Investigator Award (2006) BD Research Prize (2006) Professor Bumann's research group includes several PhD students, postdoctoral fellows, and technical staff working collaboratively on various aspects of bacterial pathogenesis. His laboratory maintains strong collaborations with University Hospitals Basel and Zurich through the NCCR AntiResist initiative, extending their research from mouse models to human patient samples infected with Staphylococcus aureus , Pseudomonas aeruginosa , and E. coli . Current projects focus on developing more physiologically relevant methods for antibiotic testing and understanding how tissue compartmentalization affects bacterial persistence during chemotherapy.

Rink-Jan Lohmanمشاهده پروفایل

پژوهشگر ارشد

• Pharmacology
• Pharmacokinetics
• Inflammatory Disease
• +۲ مورد دیگر

Rink-Jan Lohman is a Senior Research Fellow at the School of Pharmacy and Pharmaceutical Sciences, University of Queensland. With a PhD in Pharmacology from the University of Melbourne, his research spans inflammatory diseases, peptide drug development, and pharmacokinetics. He has contributed extensively to understanding protease-activated receptor-2 (PAR2) modulation and improving oral bioavailability of cyclic peptides. Education: Bachelor (Honours) of Science (Advanced), University of Melbourne Doctor of Philosophy, University of Melbourne Research interests include pharmacology with focus on anti-inflammatory peptides , oral bioavailability optimization , and protease-activated receptor mechanisms . His work on PAR2 antagonists and HDAC inhibitors has implications for arthritis, colitis, and renal disease. Key article trends reveal expertise in: Cyclic peptide design for improved stability PAR2 receptor's role in inflammation HDAC inhibition for immune modulation Opioid receptor targeting without side effects Nanocarrier systems for drug delivery Scientific contributions include grants from: NHMRC Project Grant (2015-2017) UQ Early Career Researcher Grant (2015) As an associate advisor , he has supervised PhD projects on: Bivalent opioid constructs Novel analgesic peptides Inflammatory disease drug candidates

Mark Coulthardمشاهده پروفایل

پژوهشگر

• Vascular Biology
• Sepsis Research
• Pediatric Critical Care
• +۴ مورد دیگر

Dr. Mark Coulthard is an Affiliate of the School of Biomedical Sciences within the Faculty of Health, Medicine and Behavioural Sciences at The University of Queensland. He maintains a dual focus on clinical practice as a physician and academic research, with particular expertise in pediatric critical care and vascular biology. Dr. Coulthard holds a Doctor of Philosophy of Medicine (Research) from The University of Queensland and is a Fellow of the Royal Australasian College of Physicians. His clinical training and board certification provide the foundation for his research in pediatric critical care medicine. His primary research interests focus on the Role of Eph/ephrin receptor ligand system in vascular leak in sepsis/systemic inflammatory response syndrome , exploring how this signaling pathway contributes to vascular permeability during critical illness. Another major research theme involves the Role of telemedicine in the management of critically ill children , where he has led the Queensland telepaediatric service for over 15 years. Additionally, he has developed the Paediatric Online Interactive Education (POLIE) platform to enhance medical education. Analysis of Dr. Coulthard's recent publications reveals a strong focus on sepsis research, pediatric pharmacokinetics, and telemedicine applications. His work on Eph/ephrin signaling has evolved from basic science to translational applications targeting vascular leak in sepsis. The pharmacokinetics research demonstrates his commitment to optimizing antibiotic dosing in critically ill children, while his telemedicine studies reflect a sustained effort to improve access to pediatric critical care expertise across Queensland. Dr. Coulthard has secured significant research funding from multiple sources including The Children's Hospital Foundation, NHMRC, Financial Markets Foundation for Children, and Bayer Pharma AG. His current projects focus on 'Eph receptor blockade to prevent and repair endothelial damage in systemic inflammation' and related therapeutic approaches for sepsis. Regarding supervision, Dr. Coulthard is actively involved in mentoring the next generation of researchers. He currently serves as an Associate Advisor for a PhD student investigating 'How to use antibiotics better in Paediatric Intensive Care using pharmacokinetic principles,' working alongside Professor Jeffrey Lipman and other senior researchers.

Matthew Balhoffمشاهده پروفایل

استاد

• Geologic Carbon Storage
• Enhanced Oil Recovery
• Integrated Reservoir Characterization
• +۵ مورد دیگر

Matthew Balhoff serves as Department Chair and Professor of Petroleum Engineering at The University of Texas at Austin, holding the Lois and Richard Folger Leadership Chair and Bank of America Centennial Professorship. His expertise lies in modeling subsurface fluid flow for hydrocarbon recovery and carbon sequestration using advanced computational and experimental methods. His educational background includes: B.S. in Chemical Engineering from Louisiana State University (2000) Ph.D. in Chemical Engineering from Louisiana State University (2005) Dr. Balhoff's research focuses on four main areas: developing multiscale flow simulation methods, predicting nonlinear pore-scale flow, modeling non-Newtonian fluids in recovery processes, and breakthroughs in unconventional hydrocarbon recovery. His work integrates pore-scale modeling, reservoir simulation, and experimental validation to address challenges in geologic carbon storage, enhanced oil recovery, and reservoir geomechanics. Analysis of his recent publications (2015-2020) reveals a consistent emphasis on reservoir characterization and simulation. Key contributions include novel approaches to CO2 huff-and-puff optimization, microfluidic investigations of low salinity effects, and pore-network modeling of particle retention. His research bridges computational modeling with laboratory experiments to advance recovery techniques for conventional and unconventional reservoirs. His accolades include: CSE Lockheed Martin Award for Excellence in Engineering Teaching (2022) SPE Lester C. Uren Award (2022) SPE Distinguished Member Award (2017) SPE Regional Reservoir Description and Dynamics Award (2017) SPE Young Member Outstanding Service Award (2014) Regents’ Outstanding Teaching Award (2013) SPE International Teaching Fellow Award (2012) ASEE Gulf Coast Southwest Outstanding Young Faculty Award (2011) PGE Departmental Teaching Award (2009) Information regarding specific grant funding and student advising is not provided in the available text.

Yvonne Reinwaldمشاهده پروفایل

مدرس ارشد

• Tissue Engineering
• Regenerative Medicine
• Biomedical Engineering
• +۴ مورد دیگر

Dr Yvonne Reinwald is a Senior Lecturer in Biomedical Engineering within the School of Science & Technology at Nottingham Trent University (NTU). Previously at Keele University's Institute for Science and Technology, she conducted regenerative medicine research and taught cell biomechanics, bioreactors, and biomaterials. Her expertise spans tissue engineering, regenerative medicine, and biomedical device development. Her research focuses on evaluating bioreactor performance for tissue engineering, specifically analyzing mechanical stimulation environments for cell growth and construct development. She also investigates biomedical implant characterization to establish quality control criteria for manufacturing and clinical translation, integrating biomaterials science, 3D tissue modeling, and advanced imaging techniques like microcomputed tomography. Publications from 2005-2016 reveal consistent innovation in scaffold design, bioreactor technology, and tissue construct assessment. Key contributions include methods for real-time mechanical property monitoring, scaffold interconnectivity analysis using supercritical CO2 foaming, and ultrasound-based post-processing techniques to enhance fluid transport in polymer scaffolds. Dr Reinwald received the Robert Brown Early Stage Investigator Award from the Tissue and Cell Engineering Society in 2016. Robert Brown Early Stage Investigator Award of the Tissue and Cell Engineering Society (2016) Details regarding student supervision and grant funding are not specified in the source material. She actively participates in the Tissue Engineering & Regenerative Medicine International Society, Tissue and Cell Engineering Society, and Institute of Physics and Engineering in Medicine. As a STEMNET Ambassador, she engages in public outreach to promote science, technology, engineering, and mathematics.

John-Peter Ganda-Mallمشاهده پروفایل

پژوهشگر

• Gut-Brain Axis
• Intestinal Barrier Function
• Biomedicine
• +۶ مورد دیگر

John-Peter Ganda-Mall is a Researcher at Örebro University's School of Medical Sciences , specializing in Biomedicine within the Nutrition-Gut-Brain Interactions Research Centre (NGBI). His work bridges gut barrier function and neurodegenerative disease mechanisms, with a focus on Parkinson's disease and Irritable Bowel Syndrome (IBS). His research employs advanced techniques like Ussing chamber analysis for real-time barrier modulation and sugar solution permeability tests . Postdoctoral work at Vall d'Hebron Research Institute (Spain) explored plasma cell-nerve interactions in IBS using electron microscopy . Key collaborations include teams in Barcelona and Stockholm. Doctoral thesis (2018): Non-digestible polysaccharides' effect on intestinal barrier Swedish Research Council International Postdoc Grant (2018-2020) Active projects: Probiotic effects of Akkermansia muciniphila in Parkinson's patients Scientific awards include: Swedish Research Council International Postdoc Grant

Julia Königمشاهده پروفایل

مدرس ارشد

• Nutrition Science
• Gastrointestinal Health
• Gut-Brain Axis
• +۵ مورد دیگر

Julia König is a Senior Lecturer in Medicine at the School of Medical Sciences, Örebro University, Sweden. She is also an Associate Professor, affiliated with the Nutrition-Gut-Brain Interactions Research Centre (NGBI) and the Responsive Nutrition Research Centre. Her research focuses on nutrition science and gastrointestinal health, particularly the impact of probiotics, fibres, and plant-based proteins on intestinal barriers, microbiome, and gut-brain interactions. Master’s Degree in Nutrition Science (2008), University of Hohenheim, Germany PhD in Molecular Medicine (2011), Medical University of Graz, Austria König’s research explores nutritional compounds, intestinal barrier dynamics, gut microbiota, and their roles in health and diseases like IBS and microscopic colitis. She leads EU-funded projects (Bugs4Urate) and collaborates with industrial partners such as BioGaia AB. Her work bridges clinical trials with microbiome studies. Recent publications (2024-2013) span gut-brain axis effects, probiotic interventions, gluten degradation, and intestinal barrier modulation. These studies employ methodologies like fMRI, microbiota transfer, and metabolic analysis, emphasizing interdisciplinary approaches in nutrition and gastroenterology. Director of Doctoral Studies at School of Medical Sciences (2016–present) Supervised 15+ students across levels, including 3 doctoral graduates Active in EU/PLENTY/Formas-funded projects since 2017 She contributes to academic governance as a reviewer for journals (JAMA Pediatrics, Lancet Gastroenterology) and participates in PhD defense committees. Her leadership in nutrition science and translational research underscores her impact in gut-brain axis studies.

• Condensed Matter Physics
• Nanomaterials
• 2D Materials
• +۴ مورد دیگر

Barbara Pacáková is a Researcher in the Department of Physics at the Norwegian University of Science and Technology (NTNU), focusing on synthesis and properties of low-dimensional materials including clay, MXenes, and carbon nanostructures for applications such as CO 2 capture. Her work bridges basic research on material properties and applied environmental solutions. Her research spans condensed matter physics and nanomaterials, emphasizing 2D materials like clay nanosheets and graphene. She investigates magnetic and transport properties while designing functional structures for sustainable technologies. Previous work centered on magnetic nanoparticles and carbon nanotubes, demonstrating continuity in nanoscale material innovation. Analysis of her 2017-2025 publications reveals dominant themes in 2D material synthesis (clay nanosheets, MXenes), environmental applications (CO 2 capture), and advanced characterization techniques (X-ray diffraction, synchrotron). Her work consistently explores structure-property relationships in nanomaterials, with recent studies highlighting antiferromagnetic semiconductors and swelling-deswelling transitions in nanolayered systems. No scientific awards were documented in the provided materials. While no student advisement or grant details were specified, her collaborative projects involve international consortia including the Graphene Flagship initiative, indicating significant research networking. She operates within NTNU's Soft and Complex Matter Lab and Layered Materials and Structures Lab, utilizing facilities like the NTNU Nanolab. Her outreach includes presentations at Graphene Week, Geilo PhD School, and APS March Meetings, reflecting active engagement in the global materials science community.

Gisela Beutnerمشاهده پروفایل

پژوهشگر

• Cardiology
• Mitochondrial Biology
• Cell Death
• +۳ مورد دیگر

Gisela Beutner is a Researcher at the University of Rochester's School of Medicine and Dentistry within the Department of Pediatrics, Cardiology. Her work focuses on mitochondrial energy generation and permeability transition pore dynamics in cardiac and neuronal contexts. She completed a PhD in Biology at the University of Konstanz (1997) and a postdoctoral fellowship in Pharmacology and Physiology at the University of Rochester (1998-2002). PhD, Biology, University of Konstanz (1997) Diploma, Biology, University of Osnabrück (1993) Postdoctoral Fellow, University of Rochester (1998-2002) Her research explores the mitochondrial permeability transition pore (mPTP) in health and disease, particularly its role in cardiac apoptosis and energy metabolism. Experimental models include isolated cardiac mitochondria, primary cardiomyocyte cultures, and transgenic mice. Key themes from her publications include mitochondrial protein complexes, ATP synthase, ryanodine receptors, and calcium signaling in cardioprotection and neurodegeneration. Scientific recognition includes a Young Investigator Award (2001) and a Travel Award (1996) . She holds a patent for low-intensity magnetic field devices targeting cardiac and neurological disorders (2018). Her collaborative work spans bioenergetics, molecular cardiology, and neurophysiology.

Jun Guمشاهده پروفایل

پژوهشگر

• Composite Materials
• Material Characterization
• Non-Destructive Testing
• +۵ مورد دیگر

Jun Gu is a Scientific Researcher at Vrije Universiteit Brussel (VUB), Faculty of IR, Department of Materials and Chemistry since 2019. Previously, he served as Research Assistant at VUB (1997-2013) and engaged in engineering consultancy at BYTEC BV (2013-2019). He concurrently holds an external directorship at BYTEC BVBA. His educational foundation includes a Master's degree in Material Science, culminating in the 1992 thesis Thermal Characterisation and Processibility of PPV-derivatives supervised by B. Van Mele at VUB. Dr. Gu's research centers on sustainable advanced materials , with core expertise in: Composite material systems (fiber-reinforced polymers, basalt/glass fabrics) Non-destructive characterization techniques Cement chemistry and alkali-activated binders Industrial by-product valorization (slag, copper waste) Recycling methodologies for construction materials His work bridges fundamental material science with practical engineering applications, emphasizing circular economy principles in construction. Analysis of recent publications (2023-2025) reveals three dominant research thrusts: (1) Development of waste-derived composites using copper slag and basalt, (2) Advanced non-destructive evaluation methods for composite mechanical properties, and (3) thermal reactivation techniques for recycled cementitious materials. These efforts consistently target sustainable alternatives to conventional construction materials through rigorous experimental validation. Dr. Gu has secured substantial research funding through competitively awarded projects: FWO_COMPOSITE Project (2009-2013): Fatigue behavior characterization of fiber reinforced plastics European Project 'Concrete to High Performance Concrete' (2019-2022) Vlaio ICON Projects (2020-2023 & 2024-2028): Advanced material systems development Earlier initiatives including GOA, GBOU, SBO, and FWO_SPIF covering composite manufacturing, permeability modeling, and rapid prototyping His collaborative network spans VUB research groups and international partners, particularly evident in co-authored publications with Rahier, Sol, and Meza Hernandez. Current efforts focus on scaling waste-valorization technologies through the ongoing Vlaio ICON project (2024-2028), targeting industrial implementation of sustainable material solutions.

Marcela Konjevodمشاهده پروفایل

مدرس ارشد

• Posttraumatic Stress Disorder Research
• Alzheimer's Disease Research
• Metabolomics
• +۴ مورد دیگر

Marcela Konjevod serves as a Senior Lecturer at the Ruđer Bošković Institute in Zagreb, Croatia, within the Division of Molecular Medicine's Laboratory of Molecular Neuropsychiatry. Her research integrates molecular psychiatry with advanced omics technologies to investigate neuropsychiatric disorders, particularly focusing on combat veterans with PTSD and neurodegenerative conditions like Alzheimer's disease. Her primary research interests center on metabolomic, lipidomic, and glycomic profiling to identify biomarkers in PTSD and dementia. She examines neuroinflammatory pathways, gut-brain axis interactions, and genetic/epigenetic factors influencing disease progression and treatment response. Key areas include the role of neurosteroids (DHEA/DHEAS) and neurotrophic factors (BDNF) in neuroprotection, alongside investigations into serotonin and catecholamine systems in psychiatric and neurological disorders. Her work bridges basic science with clinical applications through extensive collaboration with Croatian medical institutions. Analysis of her recent publications reveals a strong emphasis on applying multi-omics approaches to PTSD biomarker discovery, with growing focus on neurodegenerative mechanisms. Her team consistently demonstrates how metabolomic alterations correlate with clinical symptoms in veterans, while recent work explores DHEA(S) and BDNF as therapeutic targets for Alzheimer's and vascular dementia models. This trajectory highlights her transition from biomarker identification toward mechanistic therapeutic development. Dr. Konjevod operates within the Laboratory of Molecular Neuropsychiatry, a dynamic research environment conducting interdisciplinary studies on molecular mechanisms underlying psychiatric and neurodegenerative disorders. The laboratory employs advanced techniques including mass spectrometry-based metabolomics, genetic/epigenetic analysis, and cellular/animal models to investigate neuroinflammatory pathways and develop targeted interventions for conditions like PTSD and Alzheimer's disease.

Mary Beth Brownمشاهده پروفایل

دانشیار

• Cardiopulmonary Rehabilitation
• Exercise Physiology
• Lung Disease
• +۵ مورد دیگر

Mary Beth Brown, PT, PhD is an Associate Professor in the Department of Rehabilitation Medicine at the University of Washington School of Medicine. She joined UW in December 2018 after being promoted to Associate Professor with tenure in the Doctor of Physical Therapy program at Indiana University. Prior to academia, Dr. Brown practiced as a licensed physical therapist for nearly a decade in hospital-based outpatient settings. Dr. Brown's educational background includes: Postdoctoral fellowship in Pulmonary and Critical Care at Indiana University School of Medicine PhD in Applied Physiology from Georgia Institute of Technology Master's in Physical Therapy from University of Miami School of Medicine Undergraduate degree in Exercise Science from Lenoir-Rhyne College Dr. Brown directs the Brown Lab for Optimization of Exercise as Therapy in Cardiopulmonary Disease, which focuses on improving how exercise is used as medicine for patients with lung diseases. Her research addresses the gap in data needed to appropriately prescribe exercise for specific patient groups, particularly those with pulmonary arterial hypertension, pulmonary embolism, cystic fibrosis, and lymphangioleiomyomatosis (LAM). Through both clinical and animal studies, her lab defines the physiological and biochemical consequences and functional outcomes following acute and chronic exercise in lung disease to optimize exercise prescription. Her research program is funded by the National Heart, Lung, and Blood Institute of the NIH, The American Heart Association Scientist Development Grant, The Pulmonary Hypertension Association, The American Thoracic Society, and The Lymphangioleiomyomatosis Foundation. Dr. Brown has published extensively on exercise interventions in cardiopulmonary disease, with recent work focusing on mobile health platforms to deliver exercise prescriptions for patients with interstitial lung disease and LAM. Dr. Brown has received several notable awards: New Investigator Award from the American College of Sports Medicine (2016) Cardiovascular & Pulmonary Research Award from the Combined Sections Meeting of the American Physical Therapy Association (2015) 'Emerging Excellence in Research' from the School of Health and Rehabilitation (2014) 2022 Established Investigator Award from The LAM Foundation Dr. Brown mentors numerous students in the Doctor of Physical Therapy program and PhD program in Rehabilitation Science. Her current research projects include "LAMFit," an mHealth program to expand access to exercise benefits for LAM patients, and studies investigating exercise interventions for idiopathic pulmonary fibrosis and Duchenne Muscular Dystrophy. Her lab employs both human clinical studies and rodent models to investigate exercise hemodynamics and physiological responses to acute and chronic exercise.

Melanie Esselenمشاهده پروفایل

استاد

• Food Chemistry
• Toxicology
• Pharmacology
• +۷ مورد دیگر

Prof. Dr. Melanie Esselen is a Professor at the University of Münster, Germany, where she leads the Esselen research group focused on food chemistry and toxicology. Her work examines genotoxic plant substances, cell culture studies on toxicity and metabolism, and post-translational protein modifications by secondary plant compounds. She collaborates closely with Prof. Dr. Hans-Ulrich Humpf and other researchers in the field. Research Group Leader at University of Münster Active member of Food Chemistry Society (LChG) Member of German Society for Pharmacology and Toxicology (GT) Prof. Esselen's research interests center on the genotoxic and mutagenic effects of carcinogenic plant compounds, with particular focus on alkenylbenzenes like asarones and methyleugenol. Her group investigates how flavonoids influence cellular signaling cascades including the Nrf-2 pathway, apoptosis mechanisms, and DNA topology. A third research focus examines the cell toxicity of cyclopentenone prostaglandins. Her laboratory employs various test systems including the micronucleus test, comet assay, and HPRT test, along with advanced bioanalytical techniques such as ELISA, flow cytometry, Western blot, real-time PCR, and fluorescence microscopy. Analysis of Prof. Esselen's recent publications (2022-2025) reveals a strong research trajectory in food toxicology, with particular emphasis on plant-derived compounds, mycotoxins, and food additives. Her work spans multiple disciplines including analytical chemistry, molecular toxicology, and food safety assessment. A notable trend is the interdisciplinary nature of her research, bridging food chemistry with pharmacology and molecular biology to understand mechanisms of toxicity at the cellular level. 2017 Goldener Brendel – Chemistry Student Council of the University of Münster 2013 Kurt Täufel Prize for Young Scientists – Society of Food Chemistry (LChG) Prof. Esselen has supervised numerous doctoral students working on diverse topics including polyphenol metabolism, DNA damage response to plant compounds, and cellular mechanisms of food toxicants. Her research group actively collaborates with other institutions and receives funding for projects investigating food safety and toxicology. The lab maintains strong connections with professional societies including the Society for Environmental Mutation Research, German Chemical Society, and German Society for Pharmacology and Toxicology. The Esselen research group operates state-of-the-art facilities for cell culture studies, bioanalytical testing, and metabolic profiling. They maintain collaborations with other research groups both within the University of Münster and internationally, particularly in the areas of food toxicology and safety assessment.